Close Menu

NEW YORK (GenomeWeb) – The GenomeWeb Index fell nearly 1 percent in April, as disappointing preliminary earnings from Illumina and some concerns about whether Abbott would complete its acquisition of Alere dragged down the stocks of those firms.

The Dow Jones Industrial Average, which gained less than 1 percent during the month, and the Nasdaq Biotechnology Index, which gained 3 percent, outperformed the GenomeWeb Index. However, the Index outperformed the Nasdaq, which finished the month nearly 2 percent lower.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Dog DNA testing is a growing market, but there's still a lot of uncertainty about the accuracy of the results, the Boston Globe says.

A University of South Florida researcher is testing bone fragments to determine if they belong to Amelia Earhart.

In Cell this week: antisense Piwi-interacting RNA responses to endogenous retroviruses, proteomic patterns in hepatocellular carcinoma, and more.

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.